Tag: Research

Browse our exclusive articles!

London’s Crono secures €500k funding to improve sales team processes through data and AI

London-based sales tech startup Crono has secured €500,000 in pre-seed funding to invest in research, development, and technology for its AI platform. Investors include SFC Capital, Aticco Ventures, Startup Wise Guys, Magic Mind, and business angels. Crono's platform helps sales teams optimize their performance by analyzing customer data for actionable insights and customized messages. The funding will enable the company to expand across Europe and hire additional staff.

Tapping AI Tools like ChatGPT for Smarter Investment Decisions: A Guide to Consider

Boost productivity and get quick answers with AI chatbot ChatGPT. However, when it comes to financial advice, cross-checking is key. Get the pros and cons in our article.

Revolutionary Machine Learning Tool Transforms Clinical Trial Medical Coding

SDC's revolutionary machine learning tool for clinical trial medical coding is set to transform the industry with unprecedented efficiency and accuracy. Centralizing medical coding and streamlining tasks for optimal output. Visit www.sdcclinical.com for more information.

The Next Top Crypto to Surge in 2023: AI Crypto, ChatGPT, AiDoge, or ApeMax?

Discover the impact of AI on crypto and the innovative Boost-to-Earn mechanism of ApeMax, a new trailblazing cryptocurrency. Stay informed to make informed buying decisions in the ever-evolving crypto landscape.

ChatGPT: Is It Threatening Your Career?

Discover AI's potential to replace knowledge workers but lack of human touch in this article. ChatGPT, AI tool that can optimize research and writing, handle large volumes of work simultaneously. Striking a balance between AI and human workers could yield the best results.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img